Literature DB >> 19760035

The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review.

Li-Fen Chao1, Anthony Lin Zhang, Hsueh-Erh Liu, Ming-Huei Cheng, Hung-Bun Lam, Sing Kai Lo.   

Abstract

The aim of the present study was to scrutinize the evidence on the use of acupoint stimulation for managing therapy-related adverse events in breast cancer. A comprehensive search was conducted on eight English and Chinese databases to identify clinical trials designed to examine the efficacy of acupressure, acupuncture, or acupoint stimulation (APS) for the management of adverse events due to treatments of breast cancer. Methodological quality of the trials was assessed using a modified Jadad scale. Using pre-determined keywords, 843 possibly relevant titles were identified. Eventually 26 papers, 18 in English and eight in Chinese, satisfied the inclusion criteria and entered the quality assessment stage. The 26 articles were published between 1999 and 2008. They assessed the application of acupoint stimulation on six disparate conditions related to anticancer therapies including vasomotor syndrome, chemotherapy-induced nausea and vomiting, lymphedema, post-operation pain, aromatase inhibitors-related joint pain and leukopenia. Modalities of acupoint stimulation used included traditional acupuncture, acupressure, electroacupuncture, and the use of magnetic device on acupuncture points. Overall, 23 trials (88%) reported positive outcomes on at least one of the conditions examined. However, only nine trials (35%) were of high quality; they had a modified Jadad score of 3 or above. Three high quality trials revealed that acupoint stimulation on P6 (NeiGuang) was beneficial to chemotherapy-induced nausea and vomiting. For other adverse events, the quality of many of the trials identified was poor; no conclusive remarks can be made. Very few minor adverse events were observed, and only in five trials. APS, in particular acupressure on the P6 acupoint, appears beneficial in the management of chemotherapy-induced nausea and vomiting, especially in the acute phase. More well-designed trials using rigorous methodology are required to evaluate the effectiveness of acupoint stimulation interventions on managing other distress symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760035     DOI: 10.1007/s10549-009-0533-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

Review 1.  What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: an integrative overview of reviews.

Authors:  P Towler; A Molassiotis; S G Brearley
Journal:  Support Care Cancer       Date:  2013-07-19       Impact factor: 3.603

2.  The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps.

Authors:  Farah Z Zia; Oluwadamilola Olaku; Ting Bao; Ann Berger; Gary Deng; Arthur Yin Fan; Mary K Garcia; Patricia M Herman; Ted J Kaptchuk; Elena J Ladas; Helene M Langevin; Lixing Lao; Weidong Lu; Vitaly Napadow; Richard C Niemtzow; Andrew J Vickers; Xin Shelley Wang; Claudia M Witt; Jun J Mao
Journal:  J Natl Cancer Inst Monogr       Date:  2017-11-01

Review 3.  Acupuncture for cancer pain in adults.

Authors:  Carole A Paley; Mark I Johnson; Osama A Tashani; Anne-Marie Bagnall
Journal:  Cochrane Database Syst Rev       Date:  2015-10-15

Review 4.  Anticipatory nausea and vomiting due to chemotherapy.

Authors:  Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

Review 5.  Complementary and alternative therapies used by Turkish breast cancer patients undergoing chemotherapy.

Authors:  Gulbeyaz Can; Melike Demir; Adnan Aydiner
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

6.  Evaluation of chemotherapy-induced toxicity and health-related quality of life amongst early-stage breast cancer patients receiving Chinese herbal medicine in Malaysia.

Authors:  Ai Ch'i Liew; Kok-Khiang Peh; Boon Seang Tan; Wei Zhao; Balamurugan Tangiisuran
Journal:  Support Care Cancer       Date:  2019-03-26       Impact factor: 3.603

7.  Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke.

Authors:  Haidong Wei; Xi Yao; Lifang Yang; Shiquan Wang; Fan Guo; Heng Zhou; Giovanni Marsicano; Qiang Wang; Lize Xiong
Journal:  Mol Neurobiol       Date:  2013-08-14       Impact factor: 5.590

8.  Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial.

Authors:  Wolf E Mehling; E Anne Lown; Christopher C Dvorak; Morton J Cowan; Biljana N Horn; Elizabeth A Dunn; Michael Acree; Donald I Abrams; Frederick M Hecht
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-09       Impact factor: 2.629

Review 9.  The evidence for Shiatsu: a systematic review of Shiatsu and acupressure.

Authors:  Nicola Robinson; Ava Lorenc; Xing Liao
Journal:  BMC Complement Altern Med       Date:  2011-10-07       Impact factor: 3.659

10.  Effectiveness of acupressure versus isometric exercise on pain, stiffness, and physical function in knee osteoarthritis female patients.

Authors:  Amany S Sorour; Amany S Ayoub; Eman M Abd El Aziz
Journal:  J Adv Res       Date:  2013-04-08       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.